Tune in and learn about the $660 million public offering Madrigal Pharmaceuticals received to deliver novel therapeutics for nonalcoholic steatohepatitis (NASH). Hear from Bill Sibold as he shares his experience leading one of the year's most significant biotech fundraisings, the preparations and strategies behind the raise and how this milestone positions Madrigal to bring innovative treatments to patients.

Join us as Senator Robinson discusses his key role in passing SB954 - which provides Pennsylvanians better access to personalized treatments following a diagnosis of cancer and other specific diseases through biomarker testing and precision medicine. Learn about Senator Robinson's journey as the bill's prime sponsor, the collaborative efforts to get it unanimously passed in the Senate and what this milestone means for patients and Pennsylvania's healthcare system.

Tune in to this episode with Representative Mullins, recipient of the 2024 State Official of the Year Award, and learn about his pivotal role in passing HB 1754 - which requires all state-regulated health plans to cover comprehensive biomarker testing. Hear about the personal motivation Representative Mullins had to be the prime sponsor of this bill, the collaborative efforts leading to this near unanimous passage in the House of Representatives and what this milestone means for patients and ...

Ben Doranz, recipient of the 2024 Frank Baldino Bioscience CEO of the Year Award, joins Chris and Rachael this episode to discuss how he led his team through a transformative year in 2024. Under Ben's leadership, Integral Molecular secured an $8 million contract from NIAID to combat emerging viruses, as well as $2.7 million award to advance the Membrane Proteome Array for FDA qualifications as a drug development tool. If that wasn't enough, Ben also discussed the launch of Cell Surface Bio, a...

This episode features Adrian (Ad) Rawcliffe, CEO, Adaptimmune, recipient of the Life Sciences PA 2024 Patient Impact Award. Ad shares the story behind TECELRA - the first FDA approved engineered cell therapy for a solid tumor. Learn about the journey leading up to this groundbreaking approval, the challenges of bringing a cell therapy to market and the next steps for Adaptimmune in the landscape of tumor treatments.

This episode features Fred Vogt, Interim CEO at Iovance Biotherapeutics, recipient of the 2024 Patient Impact Award. In this episode, Fred shares the journey behind AMTAGVI - the first FDA approved tumor infiltrating lymphocyte (TIL) therapy. Learn about the clinical trial process, how they brought this groundbreaking treatment to market, the impact the Iovance team has on the life sciences industry and how the state of Pennsylvania is supporting Iovance's efforts to treating patients.&...

This episode features Rob Albert, CEO of B. Braun of America, the organization receiving the 2024 Patient Impact Award. Hear from Rob and discover how B. Braun took decisive action during Hurricanes Helene and Milton to secure the supply of critical I.V. fluids to hospitals affected by these disasters. Learn how they collaborated with government agencies like the Administration for Strategic Preparedness and Response (ASPR), navigated challenges, and ensured patients had the necessary r...

Adele Oliva, recipient of the 2025 Hubert J.P. Schoemaker Leadership Award joins Chris and Rachael to discuss her impact on the life sciences industry in PA supporting the growth of commercial stage healthcare companies. In this episode, hear how her career path ultimately led to finding a gap in the ecosystem and later found 1315 Capital. Learn about the best way to build a strong team and how she hopes the 1315 impact will live on for generations.

This episode features Jeffrey O'Donnell Sr., the recipient of the 2025 John Nash MedTech Leadership Award. This award recognizes an outstanding leader in the PA MedTech community who best exemplifies the spirit of innovation. Learn how Jeff's passion for medicine and curiosity led him to take leaps throughout his career that altered his life and the work of the med tech community in Pennsylvania and beyond.

Season 7 of Being a Life Sciences Leader launches with interviews with our 2025 Annual Award Honorees. Paul Frankhouser will be honored with the 2025 Scientific Achievement Award for his decades of experience bringing innovative technology to patients. Hear how Paul's 42 year career at Arrow International led to his participation in hundreds of patents and how he continues to give his expert advice to organizations in the medical technology space today

The season finale of Being a Life Sciences Leader features a LIVE recording from our Patient Summit held in November 2024. Suzanna Masartis, CEO of the Community Liver Alliance, joins Chris and Allison Nicklin of Goodwin to discuss her journey from volunteering at a young age to advocacy and collaboration with other non-profit leaders to enact change. Hear best practices on working with your local and state legislators to educate them on legislation that affects patient access.

Episode 6 features Kyle Bryant, Senior Director, rideATAXIA & Spokesperson, Friedreich's Ataxia Research Alliance (FARA). Hear Kyle's inspiring story of living with a rare disease, Friedreich's Ataxia, and how he incorporates his passion of cycling to empower those living with Friedreich's Ataxia and raise funds for research. Kyle is also co-host of the Two Disabled Dudes podcast, available wherever you listen to podcasts.

Episode 5 features Rob Long, Executive Director, Uplifting Athletes. Rob tells his inspiring story of being a D1 athlete and NFL draft prospect to persevering through a rare form of brain cancer. Tune in to learn more about Rob's experience and how Uplifting Athletes is leveraging the platform of sports to build a community that invests in the lives of people living with rare diseases.

In this episode, Lesa shares how her daughter's diagnosis of Krabbe disease and tragic passing launched her into a career of advocacy, ultimately leading to legislative action in Pennsylvania around newborn screening panels and access for patients.

In this episode hear Marie's inspiring story living with a rare disease, her motivation to help others facing rare conditions through her work with the Pennsylvania Rare Disease Advisory Council (PARDAC) and how the Conley Cushing's Disease Fund is contributing to promoting awareness.

Episode 2 features Pat Halpin-Murphy, President & Founder, and Joanne Grossi, Executive Vice President of the PA Breast Cancer Coalition. Listen to their inspiring stories and experiences, the reason hey are taking action in the fight against breast cancer, and the contributions they have made to finding a cure.

The latest episode features Kristin Smedley, mother of two children with retinal blindness. Kristin explains how she went from school teacher to advocate, sharing anecdotes of "wins and losses" in her fight for patient access.

In this episode, John Crowley, recipient of the 2024 Hubert J.P. Schoemaker Leadership Award, discusses how his children's diagnosis of a rare disease altered his career path to becoming a leader in the life sciences. Learn more about John's motivation to improve the lives of patients through his new role as President & CEO at BIO.

In this episode, Jeff Dayno, MD, recipient of the 2023 Frank Baldino Bioscience CEO of the Year Award, discusses his role as the CEO of Harmony Biosciences. Learn more about the leadership traits Jeff utilizes to combat external challenges, develop treatments for rare diseases and drive growth.